ARCHIVES

In Vote Against Tarceva As Maintenance, ODAC Seeks Stronger Survival Benefit

This article is from The Cancer Letter archive.

Vol. 35 No. 46 | December 18, 2009

Download PDF Visit The Full Archive

Related Articles

Interview with FDA’s Richard Pazdur

October 30, 2009

Evidence Lacking On Value of Vitamins to Prevent Disease, Panel Says.

June 16, 2006

NCI CTEP Approved Trials For the Month of January

January 25, 2013

After the Plenary: Don Berry: In NeoALTTO & ALTTO Trials, Neoadjuvant Response Predicts Adjuvant

July 11, 2014

AIDs Concepts Totaling $13 Million Approved By DCT Board; Will Be Funded By Special Appropriations

October 11, 1985

NIH RFA Available

August 3, 2001